-
MAY 20-22 | CHITOSE at INTERPHEX WEEK 2026: Showcasing Cell Line Development Platform Reaching 10 g/L in 5 Days
-
The University of Tokyo and Chitose Laboratory Drive New Development in Digital Design for Manufacturing Process of Antibody Drugs ―Mathematical model development of cultivation process with full utilization of data from automated experiments―
-
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
-
High-Performance Novel HAT Cell Line for Gene Therapy, Published in Molecular Therapy Methods & Clinical Development, and Ready for Commercial Use
-
Media / Editorial
2025.11.24
CHITOSE’s Resource Circulation Business Featured in Forbes Japan and The Chemical Daily
-
Paper on Novel CHO-MK Cell Line Receives 2025 Excellent Paper Award from the Society of Biotechnology, Japan
-
CHITOSE Group, Prodezi Long An Corporation and TA Vital Join Forces to Build a Sustainable Industrial Park in Vietnam
-
CHITOSE Group Announces Capital Raising of JPY 500 Million from NSK ltd. and Conclusion of Business Alliance Agreement
-
Media / Editorial
2024.07.31
Research Paper Published on CHO-MK: Novel Host Cell Line for Biopharmaceutical Manufacturing
-
MYCENAX and Chitose Laboratory Corp. to Scale-Up Production and Strengthen Marketing Activities for CHO-MK Cells
